Загрузка...
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
Neuroleptic malignant syndrome (NMS), a potentially fatal consequence due to typical neuroleptics, has been described so far. In the past few years, there has been increased use of atypical antipsychotic drugs. Cases of NMS related to atypical neuroleptics, such as olanzapine, are less common in spi...
Сохранить в:
| Опубликовано в: : | J Family Med Prim Care |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629885/ https://ncbi.nlm.nih.gov/pubmed/29026773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2249-4863.214969 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|